AI Article Synopsis
- The article has a related commentary in the same issue, offering deeper insights or critiques.
- This commentary provides an opportunity for further discussion and analysis of the original article's topic.
- Readers can gain additional perspectives by reading both the article and the commentary together.
Article Abstract
There is a Commentary on this article in this issue.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414594 | PMC |
| http://dx.doi.org/10.1182/blood.2020006695 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Nature
December 2024
CatalYm, Munich, Germany.
Cancer immunotherapies with antibodies blocking immune checkpoint molecules are clinically active across multiple cancer entities and have markedly improved cancer treatment. Yet, response rates are still limited, and tumour progression commonly occurs. Soluble and cell-bound factors in the tumour microenvironment negatively affect cancer immunity.
View Article and Find Full Text PDFChemical Resolution of an Epitope Recognized by Blood Group Antibodies Capable of Binding Both A and B Red Blood Cells.
Chembiochem
September 2024
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation.
The high specificity of human antibodies to blood group A and B antigens is impressive, especially when considering the structural difference between these antigens (tetrasaccharides) is a NHAc versus a hydroxyl group on the terminal monosaccharide residue. It is well established that in addition to anti-A and anti-B there is a third antibody, anti-A,B capable of recognizing both A and B antigens. To analyze this AB specificity, we synthesized a tetrasaccharide, where the NHAc of the A antigen was replaced with an NH.
View Article and Find Full Text PDF[Autoimmune hemolytic anemia complicated with acute kidney injury and tubulopathy due to hemoglobin casts].
Rinsho Ketsueki
March 2023
Division of Support in Community Medicine, Jichi Medical University.
A 62-year-old male patient was admitted for close monitoring of anemia (hemoglobin level, 8.2 g/dl). Hemolytic anemia was observed; however, the direct antiglobulin test (DAT) result (standard tube method) was negative.
View Article and Find Full Text PDFClinical and immunohematological characterization of autoimmune hemolytic anemia in children.
Transfus Apher Sci
June 2023
Department of Transfusion Medicine, Apollo Multispeciality Hospitals, Kolkata 700054, India.
Autoimmune Hemolytic Anemia (AIHA) in childhood is uncommon and estimated to be three per million annually under 18 years of age. Detailed immunohematological and clinical characterizations are essential for correct diagnosis of the disease and its management. In this study we described AIHA in children with regards to patient demography, underlying etiology, disease classification, antibody characterization, clinical features, degree of in vivo hemolysis and transfusion management.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!